openPR Logo
Press release

Deadline on March 22nd coming up in Lawsuit for Investors in Fate Therapeutics, Inc. (NASDAQ: FATE)

02-27-2023 10:23 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on March 22, 2023 in the lawsuit for certain investors in Fate Therapeutics, Inc. (NASDAQ: FATE).

A Deadline is coming up on March 22, 2023 in the lawsuit for certain investors in Fate Therapeutics, Inc. (NASDAQ: FATE).

A deadline is coming up on March 22, 2023 in the lawsuit filed for certain investors of Fate Therapeutics, Inc. (NASDAQ: FATE) over alleged securities laws violations by Fate Therapeutics, Inc.

Investors who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and there are strict and short deadlines running. Deadline: March 22, 2023. NASDAQ: FATE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges on behalf of purchasers of Fate Therapeutics, Inc. (NASDAQ: FATE) common shares between April 2, 2020 and January 5, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between April 2, 2020 and January 5, 2023, the Defendants made false and/or misleading statements and/or failed to disclose that the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors, that accordingly, certain the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources, that as a result, Fate had overstated the impact of the Janssen Collaboration Agreement's on Fate's long-term clinical and commercial profitability, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on March 22nd coming up in Lawsuit for Investors in Fate Therapeutics, Inc. (NASDAQ: FATE) here

News-ID: 2951266 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Fate

Douglas Cole Explores Power Freedom and Fate in The Invisible Hand
Image: https://www.globalnewslines.com/uploads/2025/11/1762565334.jpg A dark, luminous journey into human connection and the unseen forces that shape our world "As darkly glittering as a country night sky or the alleyway where puddles reflect a big city's highrises," writes Cassandra Lane in praise of The Invisible Hand [https://www.amazon.com/Invisible-Hand-Douglas-Cole-ebook/dp/B0F5WL31FH/ref], the latest novel from award-winning author and poet Douglas Cole. Image: https://www.aionewswire.com/storage/images/ckeditor//The%20Invisible%20Hand_1762540415.jpg In The Invisible Hand , readers meet Sara, whose testimony sends her father to prison before she
Monica Ageno Releases New Fantasy Romance - Sought By Fate
In a world where magic defines your worth, an untamed power threatens to topple the highest of hierarchies-and ignite an unexpected passion. Kingdom Books proudly announces the release of Sought By Fate by Monica Ageno, a magical new addition to the fantasy romance genre. Published on August 1, 2024, this spellbinding novel invites readers into a world where magic dictates societal status and forbidden desires ignite tumultuous passions. In a realm divided
Lawsuit filed for Investors who lost money with shares of Fate Therapeutics, Inc …
An investor, who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE), filed a lawsuit i over alleged violations of Federal Securities Laws by Fate Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) have certain options and for certain investors are short and strict deadlines running. Deadline: March 22, 2023. NASDAQ: FATE investors should contact the Shareholders Foundation at
"The Turn of Fate" by Martin Hicks is published
ISBN #978-1789553543 The Turn of Fate by Martin Hicks is published The maritime saga of US Confederate raider Palmetto continues About the Book: It is the autumn of 1864 and the Confederate raider Palmetto is in Far Eastern waters, where an encounter with Malay pirates and an attack by hostile islanders have left her seriously undermanned. Thomas Grover, Palmetto’s captain, must continue to elude the US warships hunting for his ship, while somehow finding a
Launch of the iNvictus Masters of Fate Fellowship Program
FOR IMMEDIATE RELEASE Contact: Edward R. Boyd,Jr. Chief Strategy Officer 919-251-8255 eboyd@invictusoffice.com INvictus Office Center Hosts the Launch of the iNvictus Masters of Fate Fellowship Program to Erase Inequities, Boost Minority Entrepreneurial, Business and Non-profit Ventures iNvictus non-profit arm, iNvictus Forward Outreach, publically unveils eight entrepreneurs selected for inaugural Masters of Fate Fellowship Forbes magazine reports 8 of 10 entrepreneurs who start a business fail within the first two years. Among the culprits: Leadership breakdowns; lack
Court Decides Fate of Miss Tilly, Magazine Mascot on April 1, 2011
Health & Fitness Magazine issues in the year 2002 featured a new mascot, a Golden Pomeranian named Tilly with her wide pumpkin-like smile. She and her best friend Gracie, an Australian shepherd mix both were the magazine mascots, posing for the pages and attending public events to represent the magazine. During the next two and a half years, Miss Tilly started her career as a dog model for a company with